Table 4.

Effect of nanocomposites on cell viability in G-361 melanoma cells

Dilution ratios	Nanocomposite extracts applied to cells
	2 wt% ZnO-HSP	4 wt% ZnO-HSP	6 wt% ZnO-HSP
Control	99.97 ± 4.78	99.97 ± 4.78	99.97 ± 4.78
1:1	99.35 ± 9.06	106.51 ± 9.22	112.45 ± 7.15
1:2	102.61 ± 13.46	109.46 ± 12.73	103.95 ± 14.11
1:4	102.70 ± 13.51	101.34 ± 9.50	104.49 ± 11.77
1:8	94.13 ± 10.33	102.42 ± 4.11	104.50 ± 7.84
P-value*	0.790	0.532	0.504

Data were given as mean ± standard deviation (n = 3)

*It was determined that PVA nanocomposites containing different ratios of ZnO-HSP had no statistical cytotoxic/proliferative effect (p < 0.05) in human G-361 melanoma cells